CA-125 blood test results are forecast ovarian cancer the best indicators
Recurrent ovarian cancer chemotherapy new method - conventional chemotherapy drug efficacy forecast molecular targeted chemotherapy Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates gene...
Protein detection help in the early diagnosis of ovarian cancer The latest research report, researchers in the search for a new blood test to help early diagnosis of ovarian cancer progress, the rate of p...
Ovarian cancer is prone than Caucasian Europe and the United States, but recently the Taiwan people with the risk of ovarian cancer is also gradually increasing its greatest danger is early diagnosis difficult, in addition to using ultrasound, CT, even tumor marker CA-125 is very difficult to predict from, although tumor marker right up inspection Broken disease not help, but CA-125 in assessing treatment efficacy rather than tomography or ultrasound also accurate.
This is in Copenhagen, Denmark Gronlund's research team recently proposed to the report, 68 of ovarian cancer patients, topotecan plus carboplatin or paclitaxel in ovarian cancer with chemotherapy on the second line, tomography, ultrasound, or serum CA-125 concentration to assess the efficacy of chemotherapy results found that CA-125 concentrations than expensive tomography or complex sonography in predicting survival, 2.6 times more accuracy.
Although the CA-125 tumor marker in the diagnosis of ovarian cancer specificity of little help, because for example, and other general ascites, abdominal tumor invasion in the CA-125 blood concentrations will increase, but the CA-125 can be used to assess ovarian cancer effect of chemotherapy is a very simple and cheap method rather than using expensive and complex procedures tomography or ultrasound to more accurately, now independent insurance management to the hospital greatly increase the burden on the circumstances, this is tantamount to the assessment of ovarian cancer prognosis good method.
American scientists invented a new ovarian cancer detection method According to the United States Agency for Research on Cancer reports, female ovarian cancer mortality is higher than that of other women of ...
Resistance of ovarian cancer treatment strategy Tumor resistance of the tumor cells to anticancer drugs that showed no reaction of the state of ovarian cancer chemotherapy failure is the ...
PNAS: The United States and find ovarian cancer early detection methods Researchers in the United States on the 10th reported that they found a blood-screening early detection of ovarian cancer and new ways to i...
Early detection of ovarian cancer is the new law Ovarian cancer early detection difficult until the inspection was coming out of the general cancer has spread, treatment too late. Research...
Group of protein in ovarian cancer diagnosis of Ovarian cancer is the female reproductive system cancer one of the three, as misprision of clinical symptoms, the lack of an effective meth...
Interferon combined with the chemotherapy treatment of ovarian cancer Austria adopted interferon combination of chemotherapy and women's ovarian cancer treatment, and achieved better than chemotherapy alone...
Taxol and carboplatin Joint effective treatment of advanced ovarian cancer
Intraperitoneal chemotherapy should be first-line therapy in ovarian cancer
Tags: abdominal, age, blood, cancer, carboplatin, cause, chemotherapy, diagnosis, early, eat, gene, method, ovarian, paclitaxel, patients, prognosis, rate, risk, second, survival, tea, therapy, time, treatment, tumor